Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2009-02-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00432-009-0554-zPMID 19205734PMCID PMC12160211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Learning Objectives.

  2016cited by this paper
• AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.

  2007cited by this paper
• Tandem high‐dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high‐risk Ewing family tumors

  2007cited by this paper
• Simultaneous inhibition of the mitogen‐activated protein kinase kinase and phosphatidylinositol 3′‐kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma

  2007cited by this paper
• EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.

  2007cited by this paper
• Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.

  2006cited by this paper
• The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy.

  2006cited by this paper
• Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.

  2006cited by this paper
• Ewing's sarcoma family of tumors: current management.

  2006cited by this paper
• Regulation of apoptosis and proliferation in Ewing's sarcoma—opportunities for targeted therapy

  2006cited by this paper
• The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

  2006cited by this paper
• Response of Non–Small Cell Lung Cancer Cells to the Inhibitors of Phosphatidylinositol 3-Kinase/Akt- and MAPK Kinase 4/c-Jun NH2-Terminal Kinase Pathways: An Effective Therapeutic Strategy for Lung Cancer

  2005cited by this paper
• Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children's Cancer Study Group Study

  2005cited by this paper
• Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

  2005cited by this paper
• Inhibition of Platelet-derived Growth Factor-induced Cell Growth Signaling by a Short Interfering RNA for EWS-Fli1 via Down-regulation of Phospholipase D2 in Ewing Sarcoma Cells*

  2005influential reference
• Pediatric malignancies provide unique cancer therapy targets

  2005cited by this paper
• EWS-ETS oncoproteins: the linchpins of Ewing tumors.

  2005cited by this paper
• Long-Term Follow Up of High-Dose Chemotherapy With Autologous Stem Cell Rescue in Adults With Ewing Tumor

  2005cited by this paper
• Inhibition of Ligand-independent ERK1/2 Activity in Kidney Proximal Tubular Cells Deprived of Soluble Survival Factors Up-regulates Akt and Prevents Apoptosis*

  2004cited by this paper
• Contribution of MEK/MAPK and PI3‐K signaling pathway to the malignant behavior of Ewing's sarcoma cells: Therapeutic prospects

  2004cited by this paper
• Targeting of EWS/FLI‐1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro

  2004cited by this paper
• Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells.

  2004cited by this paper
• Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.

  2003cited by this paper
• Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line.

  2003cited by this paper
• EWS/ETS fusions activate telomerase in Ewing's tumors.

  2003cited by this paper
• An Investigation of the MEK/ERK Inhibitor U0126 in Acute Myeloid Leukemia

  2003cited by this paper
• Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.

  2002cited by this paper
• In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors.

  2002cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells.

  2002cited by this paper
• Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.

  2002cited by this paper
• The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells.

  2002cited by this paper
• Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571

  2002cited by this paper
• Biology of EWS/ETS fusions in Ewing's family tumors

  2001cited by this paper
• Involvement of Phospholipase D in Sphingosine 1-Phosphate-induced Activation of Phosphatidylinositol 3-Kinase and Akt in Chinese Hamster Ovary Cells Overexpressing EDG3*

  2001cited by this paper
• The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition.

  2001cited by this paper
• The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition.

  2001cited by this paper
• Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family.

  2000cited by this paper
• Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells

  2000cited by this paper
• Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation

  2000cited by this paper
• Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors.

  1999cited by this paper
• Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers

  1999cited by this paper
• Activation of mitogen-activated protein kinase associated with prostate cancer progression.

  1999cited by this paper
• Phospholipase D and Its Product, Phosphatidic Acid, Mediate Agonist-dependent Raf-1 Translocation to the Plasma Membrane and the Activation of the Mitogen-activated Protein Kinase Pathway*

  1999cited by this paper
• Role of Poly(ADP-ribose) Polymerase (PARP) Cleavage in Apoptosis

  1999cited by this paper
• Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.

  1998cited by this paper
• Increased activity of oleate-dependent type phospholipase D during actinomycin D-induced apoptosis in Jurkat T cells.

  1998cited by this paper
• Transient Poly(ADP-ribosyl)ation of Nuclear Proteins and Role of Poly(ADP-ribose) Polymerase in the Early Stages of Apoptosis*

  1998cited by this paper
• Hyperexpression of mitogen-activated protein kinase in human breast cancer.

  1997cited by this paper
• Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.

  1995cited by this paper
• EWS/Fli-1 chimeric protein is a transcriptional activator.

  1993cited by this paper

• Signaling pathways and targeted therapies in Ewing sarcoma.

  2024cites this paper
• Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma

  2023cites this paper
• The spectrum of cell death in sarcoma.

  2023cites this paper
• Thymic Immunosuppressive Pentapeptide (TIPP) Showed Anticancer Activity in Breast Cancer and Chronic Myeloid Leukemia Both In Vitro and In Vivo.

  2021cites this paper
• miR-185 suppresses progression of Ewing’s sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways

  2018cites this paper
• mir-185 suppresses progression of ewing’s sarcoma via inhibiting the Pi3K/aKT and Wnt/ β -catenin pathways

  2018cites this paper
• Targeting protein kinases to reverse multidrug resistance in sarcoma.

  2016cites this paper
• PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor/Akt and mTOR signaling pathways.

  2016cites this paper
• Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance

  2015cites this paper
• Identification of Subtype-specific Pathogenetic Aberrations in Soft Tissue Sarcoma utilising High-resolution Genomic Copy Number Analysis

  2014cites this paper
• MiR‐125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway

  2014cites this paper
• Ewing Sarcoma Cells Secrete EWS/Fli-1 Fusion mRNA via Microvesicles

  2013cites this paper
• Protective Effect of Modified Human Acidic Fibroblast Growth Factor against Actinomycin D-Induced NRK52E Cells Apoptotic Death

  2013cites this paper
• Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration

  2013cites this paper
• EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.

  2013cites this paper
• PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma.

  2012cites this paper
• PRAS 40 is a functionally critical target for EWS repression in Ewing ' s sarcoma

  2012cites this paper
• Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen‐activated protein Kinase (MAPK) and Phosphatidylinositol‐3‐kinase (PI3K)/AKT pathways

  2012cites this paper
• Tumor and Stem Cell Biology PRAS 40 Is a Functionally Critical Target for EWS Repression in Ewing Sarcoma

  2012cites this paper
• Ewing's sarcoma: overcoming the therapeutic plateau.

  2012cites this paper
• Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.

  2012cites this paper
• MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions

  2012cites this paper
• Synthetic siRNA targeting the breakpoint of EWS/Fli‐1 inhibits growth of Ewing sarcoma xenografts in a mouse model

  2011cites this paper
• EWS/Fli‐1 chimeric fusion gene upregulates vascular endothelial growth factor‐A

  2010cites this paper
• Vers une thérapeutique ciblée du sarcome d’Ewing par une stratégie antisens

  2009cites this paper
• Oncotargets and Therapy Dovepress Dovepress Primary Paraesophageal Ewing's Sarcoma: an Uncommon Case Report and Literature Review

  year unknowncites this paper